Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.24.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 9 Months Ended
Sep. 30, 2024
Accounting Policies [Abstract]  
SCHEDULE OF OTHER CURRENT ASSETS

Other current assets consisted of the following as of September 30, 2024 and December 31, 2023:

 

    September 30, 2024     December 31, 2023  
Lab supplies   $ 1,220     $ 1,227  
Prepaid expenses     441       590  
Other     43       24  
Total other current assets   $ 1,704     $ 1,841  
SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE

 

                         
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2024     2023     2024     2023  
Basic weighted average number of common shares     4,393       4,319       4,380       4,313  
Potential dilutive effect of stock-based awards     30       -       24       42  
Diluted weighted average number                                
of common shares     4,423       4,319       4,404       4,355  

SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

 

                         
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2024     2023     2024     2023  
Options     288       469       288       394  
Restricted stock units (RSUs)     145       277       145       277  
Anti-dilutive securities     433       746       433       671